Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2016-08-31 Regulatory Filings
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Biotage investerar i rening av biomolekyler
Regulatory Filings Classification · 99% confidence The document is a press release from Biotage AB dated August 31, 2016, announcing a strategic investment (15 MDKK) via subscription of newly issued shares in a Danish company, Chreto Aps, to develop products for biomolecule purification. This involves capital structure change (issuing new shares for investment) and a strategic corporate action (M&A/investment). Since the core action is an investment involving the issuance of new shares and acquiring a stake in another company, it directly relates to financing activities and capital structure changes. This aligns best with the 'Capital/Financing Update' (CAP) definition. Although it involves an investment in another company (which could suggest M&A/TAR), the primary focus is the financing aspect (subscribing new shares) and the strategic capital deployment. It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). It is a specific announcement about a financing/capital move.
2016-08-31 Swedish
Biotage invests in biomolecule purification
Share Issue/Capital Change Classification · 99% confidence The document is a press release from Biotage AB dated August 31, 2016, announcing a strategic investment (subscription of new shares) in a Danish company, Chreto Aps, related to biomolecule purification technology. This announcement details a financing/investment activity and potential future acquisition rights. This fits best under 'Capital/Financing Update' (CAP), as it concerns the company's capital structure change via investment and potential future acquisition. It is not a standard regulatory report (10-K, IR, ER) nor a general regulatory announcement (RNS), but a specific corporate action related to financing/M&A strategy.
2016-08-31 English
Interim / Quarterly Report 2016
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-June 2016. It contains comprehensive financial statements, including income statements, balance sheets, cash flow analysis, and management commentary on business performance, risks, and outlook. It is not an announcement of a report, but the report itself, containing substantive financial data. Therefore, it fits the definition of an Interim/Quarterly Report (IR). H1 2016
2016-08-11 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim report' for the period January - June 2016. It contains comprehensive financial statements, including income statements, balance sheet items, cash flow analysis, and management commentary on business performance. It is not an announcement of a report, but the report itself, containing substantive financial data. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2016
2016-08-11 English
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 99% confidence The document explicitly details a change in shareholding ('Holder: Varenne AB', 'Reason for major shareholding notification Sell') and reports the resulting percentage of voting rights and shares held by the entity. This structure perfectly matches the definition of a Major Shareholding Notification. The filing code for this is MRQ.
2016-06-01 English
Biotage AB (publ) – styrelseledamoten Anders Walldov lämnar sina uppdrag
Board/Management Information Classification · 98% confidence The document is a press release from Biotage AB dated June 1, 2016. The core content announces that a board member, Anders Walldov, has divested all his shares and will resign from his board position after the August 10, 2016, board meeting. This directly relates to changes in the company's board of directors and senior management structure. This aligns perfectly with the definition for Board/Management Information (MANG). The document is short and is a direct announcement, not a link to a larger report.
2016-06-01 Swedish

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.